COVID-19 is caused by a new coronavirus that is spreading across the globe, with outbreaks in more than 190 countries including Canada. The global research community has responded quickly, with the Canadian Government alone already contributing more than $50 million dollars (CAD) to COVID-19 research, including several grants made to Maritime researchers.
At the MSSU, we are working with our partners across the provincial health systems to prioritize support for Maritime researchers studying COVID-19, the pandemic response, and its impact on communities.
Researchers are working quickly and under unprecedented pressures. The MSSU is here to help. If you’re doing COVID-19 research in New Brunswick, Nova Scotia, or Prince Edward Island, we offer free research consultations.
Our staff have expertise in:
- Qualitative and Quantitative Research Methods
- Project Management
- Evidence Synthesis
- Knowledge Translation and Communications
- Patient and Public Engagement
- Privacy and Ethics
- Administrative Health Data Access and Services
Our work is collaborative by design, and we can help researchers connect with each other, health administrators, and policy-makers who are working in related areas. Similarly, we can supports decision-makers who are looking for researchers to help with projects addressing specific evidence needs.
By maintaining a list of active COVID-19 research projects in NB and PEI as well as collaborating with Nova Scotia Health Authority (NSHA), we are able to facilitate collaborations, help share findings, and reduce the chance of duplicating efforts in this rapidly evolving field of work.
If you’re doing COVID-19 research, contact us at firstname.lastname@example.org to explore how we can help.
The rapid response to the COVID-19 pandemic means that the available information is constantly changing, as we learn more about this new disease, the efficacy of various responses, and the impact on our communities.
To help our community cope with the unprecedented volume of information, we will have created a collection of COVID-19 resources, and will share information on the MSSU Twitter account.
Need help making sense of available research? If you’re a Maritime-based researcher, you can request a research consultation with our Evidence Synthesis Coordinator.
- End-of-Life Care in Times of Pandemic: A Rapid Review of the Literature (April 15, 2020)
- Rapid response report on COVID-19 in New Brunswick: March 31, 2020
- Update: Rapid response report on COVID-19 in New Brunswick: April 14, 2020
- Update: Rapid response report on COVID-19 in New Brunswick: April 27, 2020
- Rapid Response Report on Dedicated Resources for COVID-19: April 8, 2020
- Rapid response report on lifting restrictions for COVID-19: April 16, 2020
- Lifting restrictions for COVID-19: Implications for New Brunswick April 26, 2020
COVID-19 Background Summaries
A series of background summaries on potential treatments for COVID-19 were created for the CO-VIC study. These summaries give a snapshot of evidence available at the time. Given the rapid pace of COVID-19 research, it is possible that some of the information is now out of date. If you’re interested in up-to-date information on any of these topics, please reach out to our Evidence Synthesis Coordinator, Leah Boulos at LeahM.Boulos@nshealth.ca.
- Remdesivir – Aug. 6, 2020
- Lopinavir/ritonavir (Kaletra) – June 3, 2020; UPDATE: Lopinavir/ritonavir – July 13, 2020
- Clinical characteristics of patients with severe COVID-19 – July 2, 2020
- Hydroxychloroquine – June 22, 2020
- Dexamethasone (Ozurdex) – June 17, 2020
- Baricitinib (Olumiant) – June 17, 2020
- MSSU supports CO-VIC Study – August 11, 2020
- Joining forces to support primary care during and after COVID-19 – July 22, 2020
- COVID-19 Rapid Response Reports support government response in New Brunswick – July 15, 2020
- New rapid literature review on end-of life care during pandemic – May 11, 2020
- NB-IRDT COVID-19 projections show good news for NB – April 16, 2020
- New MSSU COVID-19 Resource Guide – April 9, 2020
- MSSU work arrangements during COVID-19 outbreak – March 17, 2020